Monique A. Hartley-Brown is an Assistant Professor and member of the Faculty of Medicine at Harvard Medical School. She is a medical oncologist specializing in multiple myeloma clinical care who treats patients at the Jerome Lipper Multiple Myeloma Center at the Dana-Farber Cancer Institute. She received her medical degree from New York University Grossman School of Medicine in 2004. Some of her accolades include being a prior recipient of the John W.V. Cordice, Sr., Honors award in 2004 from New York University School of Medicine, recipient of the K30 Scholarship award for research and career development in 2008 from the University of South Florida, and recipient of the Fellow Scholarship award in 2010 from the American Society of Oncology (ASCO). She joined the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute in 2021. She is actively involved in the American Society of Hematology (ASH) as an ambassador, mentor, and grant reviewer. She is also very active within the Alliance for Clinical Trials, as a member of the Multiple Myeloma committee, dedicated to working within the consortium to advance clinical trials and novel therapies for advancing treating outcomes for patients with multiple myeloma.
Monique A. Hartley-Brown is an Assistant Professor and member of the Faculty of Medicine at Harvard Medical School. She is a medical oncologist specializing in multiple myeloma clinical care who treats patients at the Jerome Lipper Multiple Myeloma Center at the Dana-Farber Cancer Institute. She received her medical degree from New York University Grossman School of Medicine in 2004. Some of her accolades include being a prior recipient of the John W.V. Cordice, Sr., Honors award in 2004 from New York University School of Medicine, recipient of the K30 Scholarship award for research and career development in 2008 from the University of South Florida, and recipient of the Fellow Scholarship award in 2010 from the American Society of Oncology (ASCO). She joined the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute in 2021. She is actively involved in the American Society of Hematology (ASH) as an ambassador, mentor, and grant reviewer. She is also very active within the Alliance for Clinical Trials, as a member of the Multiple Myeloma committee, dedicated to working within the consortium to advance clinical trials and novel therapies for advancing treating outcomes for patients with multiple myeloma.